{
    "patient": {
        "Name": "Eric Rogers",
        "DateOfBirth": "1953-01-19",
        "Sex": "Female",
        "Diagnosis": "Small cell carcinoma",
        "BodyPart": "Prostate",
        "Physician": "Dr. Michelle Anderson",
        "TreatingInstitution": "Dorsey-Robertson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Prostate",
            "CollectedDate": "2023-07-13",
            "ReceivedDate": "2023-07-16",
            "TumorPercentage": "34%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-07-18",
            "ReceivedDate": "2023-07-18"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "FGFR1",
                "DNA Alteration": "c.1966A>G",
                "GeneMutation": "p.K656E Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "33.56%"
            },
            {
                "Gene": "HRAS",
                "DNA Alteration": "c.35G>T",
                "GeneMutation": "p.G12V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "9.39%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "HBB",
                "DNA Alteration": "c.79G>A",
                "GeneMutation": "p.E122Q Spliceregionvariant-GOF",
                "VariantAlleleFraction": "10.29%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G12X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "5.71%"
            },
            {
                "Gene": "SRSF2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R156X Nonsense-LOF",
                "VariantAlleleFraction": "14.59%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": []
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "40 m/Mb",
            "Tmbpercentile": "92%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}